Filter
1860
Filtered Results: 1860
Text search:
M.
Stahl
Featured
Recommendations
186
New Publications
448
Language
Document type
No document type
1078
Studies & Reports
327
Guidelines
259
Manuals
103
Strategic & Response Plan
39
Training Material
21
Fact sheets
17
Situation Updates
10
Infographics
3
Resource Platforms
2
Online Courses
1
Countries / Regions
India
100
Global
68
Kenya
48
South Africa
46
Western and Central Europe
42
Nigeria
32
Ethiopia
30
Africa
29
Uganda
29
Congo, Democratic Republic of
24
Malawi
22
Latin America and the Carribbean
22
Zambia
22
Syria
21
Burkina Faso
21
Tanzania
20
Myanmar / Burma
20
Sierra Leone
19
Senegal
19
Nepal
18
Eastern Europe
17
Bangladesh
16
Ukraine
15
Asia
14
Benin
13
Rwanda
13
Cameroon
13
Lesotho
12
Ghana
12
Philippines
12
Cambodia
12
Liberia
12
Zimbabwe
11
Central African Republic
11
Indonesia
11
Russia
9
South Sudan
9
Germany
8
South–East Asia Region
8
Namibia
8
Haiti
7
West and Central Africa
7
Botswana
7
Madagascar
7
Mozambique
6
Sudan
6
Georgia
6
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Lebanon
5
Brazil
5
Iraq
5
Eswatini/ Swaziland
5
Pakistan
5
Niger
4
USA
4
Venezuela
4
East and Southern Africa
4
Vietnam
4
Mali
4
Chad
4
Tajikistan
3
Turkey
3
Albania
3
Burundi
3
Guinea
3
Jordan
3
Yemen
3
Colombia
2
Chile
2
Canada
2
Kyrgyzstan
2
Afghanistan
2
Morocco
2
Mongolia
2
Western Pacific Region
2
United Kingdom
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Papua New Guinea
2
Moldova
2
Sri Lanka
2
Poland
2
Libya
2
Somalia
2
North Macedonia
1
Thailand
1
Mexico
1
Gambia
1
Iran
1
Fiji
1
Singapore
1
Laos
1
Congo-Brazzaville
1
Peru
1
Malaysia
1
Italy
1
Armenia
1
Hungary
1
Saudi Arabia
1
Paraguay
1
North America
1
Japan
1
Denmark
1
France
1
Tunisia
1
Latvia
1
Greece
1
Angola
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
647
Clinical Guidelines
200
Public Health
94
Women & Child Health
91
Key Resources
73
Capacity Building
34
Pharmacy & Technologies
34
Toolboxes
HIV
198
Mental Health
162
COVID-19
111
TB
104
Planetary Health
61
Conflict
59
Caregiver
56
NTDs
53
Rapid Response
48
NCDs
46
Disability
43
AMR
38
Pharmacy
33
Natural Hazards
28
Ebola
28
Refugee
27
Global Health Education
25
Health Financing Toolbox
21
Specific Hazards
19
Cholera
11
Social Ethics
7
Zika
6
Polio
5
South Sudan
1
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscitator, is indispensable medical device to save newborns from asphyxia at birth. For the efficient use of...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Healthy communities rely on well-functioning ecosystems. They provide clean air, fresh water, medicines and food security. They also limit disease and stabilize the climate. But biodiversity loss is happening at unprecedented rates, impacting human health worldwide, according to a new state of knowl...
Analysis on World about Agriculture, Food and Nutrition and more; published on 23 Sep 2021 by ECA, ECLAC and 3 other organizations
Nurses' perceptions about providing spiritual care
This is the sixth of our 11-paper supplement entitled “Community Health Workers at the Dawn of New Era”. Expectations of community health workers (CHWs) have expanded in recent years to encompass a wider array
of services to numerous subpopulations, engage communities to collaborate with and to...
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
In this era, grand challenges lies in biodiversity loss, climate change, and global noncommunicable diseases signify that planet and humanity are in crisis. Scholarly evidence from human and animal kingdom suggest that there is an optimism in planetary health which can provide a unique and novel con...
24 Nov. 2021
Action against gender-based violence being pushed to the outlying margins of the global COVID-19 response
A new Oxfam report shows an undeniable increase in gender-based violence (GBV) during the COVID-19 pandemic around the world to which too many governments and donors are not doi...
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a...
This version of the glossary is substantially changed from the original. Some terms have been omitted, many have been modified in light of practical experiences and the evolution in concepts, and new terms have been added. The list of terms is not intended to be either exhaustive or exclusive, and d...
This report provides updated data on suicide in the Region of the Americas and is issued every five years, this being the fourth edition. In addition to including analysis similar to previous reports (suicide according to age, sex, as well as methods used), this report includes an expanded set of an...
Multi-sectoral Cholera Elimination Plan
(Synthesis Report 2021) [EN] - World Analysis on World about Agriculture, Climate Change and Environment, Drought, Flood and more; published on 09 Dec 2021 by FAO
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
This document focus on the direct consequences of the virus (morbidity and mortality) in specific populations and on the results of measures aimed at mitigating the spread of the virus, with indirect impacts on socio-economic conditions. In this complex scenario, the gender approach has not received...
